ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260231.1	Avagacestat	Bladder urothelial carcinoma	0.033675253	Resistant
ENSG00000260231.1	Avagacestat	Pancreatic adenocarcinoma	0.006374455	Sensitive